Febra Ptí Ltd (manufacturing, packaging, labeling, responsible for batch release)

Ukraine

All drugs from this manufacturer

KAFNEA

The drug is used for the short-term treatment of apnea (breathing pauses) in preterm infants with a gestational age of 28 to 33 weeks.

Dosage form: solution for injection

Active substance	Dosage
caffeine	20 mg/2 ml